MannKind(美國)

MannKind Corporation

美國MannKindCorporation www.mannkindcorp.com胰島素吸入設(shè)備生產(chǎn)商MannKindCorpMannKindCorporation(Nasdaq:MNKD)isabiopharmaceuticalcompanythatfocusesonthediscovery,developmentandcommercializationoftherapeuticproduct sfordiseasessuchasdiabetesandcancer.Ourleadinvestigationalproductcandidate,AFREZZA™,isanultrarapid-actinginsulin.WehavesubmittedanewdrugapplicationtotheFDArequestingapprovalofAFREZZAforthetreatmentofadultswithtype1ortype2diabetesforthecontrolofhyperglycemia.ThepharmacokineticprofileofAFREZZAsetsitapartfromallotherinsulinproducts.AFREZZAparticlesdissolveuponcontactwiththelungsurface,releasinginsulinthatrapidlyentersthebloodstream.Itachievespeakinsulinlevelswithin12-14minutesofadministration,whichmorecloselymimicsthenaturalreleaseofinsulinthananyotherinsulinpreparation.Inourclinicaltrials,wehaveobservedthatp